SCHEMBL24625607

SCHEMBL24625607

Cc1ccc2nc(C)nc(NCc3cccc(C(F)(F)F)c3C)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 3/20 0.41
▸ LMNA P02545 3/20 0.41
▸ CTNNB1 P35222 2/20 0.40
▸ TCF7L2 Q9NQB0 2/20 0.40
▸ PDE5A O76074 2/20 0.40
▸ USP1 O94782 2/20 0.38
▸ WDR48 Q8TAF3 2/20 0.38
▸ EGFR P00533 1/20 0.38
▸ TSHR P16473 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ PTK2 Q05397 1/20 0.38
▸ CYP3A4 P08684 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ ACP1 P24666 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ CD38 P28907 1/20 0.37
▸ ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24625441 0.84 SOS1 (0.38) SOS1LMNAUSP1WDR48EGFR
SCHEMBL24625281 0.84 SOS1 (0.37) SOS1LMNAUSP1WDR48EGFR
SCHEMBL24625447 0.84 SOS1 (0.37) SOS1LMNAEGFRCYP3A4CD38
SCHEMBL24625393 0.83 EGFR (0.40) SOS1LMNAEGFRTSHRHTT
SCHEMBL24625149 0.82 SOS1 (0.46) SOS1LMNAEGFRTSHRHTT
SCHEMBL24625163 0.81 EGFR (0.39) SOS1LMNAEGFRTSHRHTT
SCHEMBL24625210 0.80 CD38 (0.36) SOS1LMNAEGFRCYP3A4ACP1
SCHEMBL24625534 0.80 PIK3C2B (0.37) SOS1LMNAEGFRTSHRHTT
SCHEMBL24802560 0.80 CD38 (0.46) SOS1LMNAPDE5AUSP1WDR48
SCHEMBL25020745 0.80 SOS1 (0.40) SOS1CYP3A4CD38P2RX7KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022148442-A1 6-SUBSTITUTED PHOSPHORYL QUINAZOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 武汉人福创新药物研发中心有限公司 2022-07-14 — — WO disclosed
Send feedback